http://orcid.org/0000-0002-9713-0826
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xi Gu, Ying Wang, Hanxun Wang, Hairui Wu, Wei Li, Jian Wang & Ning Li. (2021) Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension. Journal of Biomolecular Structure and Dynamics 39:11, pages 3912-3923.
Read now
Read now
Xue Yang, Lina Wang, Lianjun Lin & Xinmin Liu. (2020) Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer. Cancer Management and Research 12, pages 6363-6371.
Read now
Read now
Michael McGee, Nicholas Whitehead, Scott Twaddell & Nicholas Collins. (2019) Pulmonary hypertension in patients with a history of intravenous drug use. Current Medical Research and Opinion 35:6, pages 1097-1101.
Read now
Read now
Articles from other publishers (35)
Takayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, Kentaro Fujimoto, Sae Yumita, Takamasa Ishino, Keita Ogawa, Terunao Iwanaga, Keisuke Koroki, Hiroaki Kanzaki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Sadahisa Ogasawara, Shingo Nakamoto, Tetsuhiro Chiba, Jun Kato & Naoya Kato. (2023) Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients. Scientific Reports 13:1.
Crossref
Crossref
Syed Mohammed Basheeruddin Asdaq, Muath Mousa Almutairi, Marwan Suleiman Alharbi, Faisal Ghazi Alharbi, Abdullah Abdulrahman Alharbi, Saleh Saud Al-Harbi, Ali Ibrahim Almoteer, Ahmad Alenazi, Abdullah Saud Altayar, Raed Alharbi, Awwadh Alqarni, Bader Hussain Alamer, Ebtesam Abdulrahman Jibreel, Syed Arif Hussain & Syed Imam Rabbani. (2023) Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia. International Journal of Pharmacology 19:4, pages 585-594.
Crossref
Crossref
Joachim Neumann, Britt Hofmann, Stefan Dhein & Ulrich Gergs. (2023) Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease. International Journal of Molecular Sciences 24:5, pages 4765.
Crossref
Crossref
Marc Humbert, Gabor Kovacs, Marius M. Hoeper, Roberto Badagliacca, Rolf M.F. Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M. Olsson, Joanna Pepke-Zaba, Jennifer K. Quint, Göran Rådegran, Gerald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean-Luc Vachiery, Anton Vonk Noordegraaf, Marion Delcroix & Stephan Rosenkranz. (2023) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal 61:1, pages 2200879.
Crossref
Crossref
Taylor Desmarais, Jenny Yang, Anna Narezkina & Timothy Fernandes. (2023) Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review. Respiratory Medicine 206, pages 107071.
Crossref
Crossref
Takatoshi Suzuki, Ichizo Tsujino, Wataru Harabayashi, Hideki Shima, Junichi Nakamura, Takahiro Sato, Masaru Suzuki, Yukari Takeda & Satohi Konno. (2023) Pulmonary arterial hypertension in an 80-year-old man with long-term use of cyclophosphamide. Respiratory Medicine Case Reports 44, pages 101867.
Crossref
Crossref
Alex Hlavaty, Matthieu Roustit, David Montani, Marie‐Camille Chaumais, Christophe Guignabert, Marc Humbert, Jean‐Luc Cracowski & Charles Khouri. (2022) Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis. British Journal of Clinical Pharmacology 88:12, pages 5227-5237.
Crossref
Crossref
Li Gao, Lina Shi & Qianqian Liu. (2022) Effectiveness and tolerability of adjunctive perampanel in the treatment of pediatric patients with uncontrolled epilepsy: A retrospective, single-center, real-world study. Epilepsy & Behavior 137, pages 108961.
Crossref
Crossref
Marc Humbert, Gabor Kovacs, Marius M Hoeper, Roberto Badagliacca, Rolf M F Berger, Margarita Brida, Jørn Carlsen, Andrew J S Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M Olsson, Joanna Pepke-Zaba, Jennifer K Quint, Göran Rådegran, Gerald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean Luc Vachiery, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz, Markus Schwerzmann, Anh Tuan Dinh-Xuan, Andy Bush, Magdy Abdelhamid, Victor Aboyans, Eloisa Arbustini, Riccardo Asteggiano, Joan Albert Barberà, Maurice Beghetti, Jelena Čelutkienė, Maja Cikes, Robin Condliffe, Frances de Man, Volkmar Falk, Laurent Fauchier, Sean Gaine, Nazzareno Galié, Wendy Gin-Sing, John Granton, Ekkehard Grünig, Paul M Hassoun, Merel Hellemons, Tiny Jaarsma, Barbro Kjellström, Frederikus A Klok, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Irene Lang, Basil S Lewis, Ales Linhart, Gregory Y H Lip, Maja Lisa Løchen, Alexander G Mathioudakis, Richard Mindham, Shahin Moledina, Robert Naeije, Jens Cosedis Nielsen, Horst Olschewski, Isabelle Opitz, Steffen E Petersen, Eva Prescott, Amina Rakisheva, Abilio Reis, Arsen D Ristić, Nicolas Roche, Rita Rodrigues, Christine Selton-Suty, Rogerio Souza, Andrew J Swift, Rhian M Touyz, Silvia Ulrich, Martin R Wilkins & Stephen John Wort. (2022) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 43:38, pages 3618-3731.
Crossref
Crossref
Esraa M. Zeidan, Mohammad Akbar Hossain, Mahmoud El-Daly, Mohammed A. S. Abourehab, Mohamed M. A. Khalifa & Ashraf Taye. (2022) Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension. Journal of Clinical Medicine 11:17, pages 5219.
Crossref
Crossref
Mansoor C. Abdulla. (2022) Cardiac Amyloidosis Presenting as Isolated Severe Pulmonary Artery Hypertension. Indian Journal of Cardiovascular Disease in Women 7, pages 103-105.
Crossref
Crossref
Manuel Ramos-Casals, Alejandra Flores-Chávez, Pilar Brito-Zerón, Olivier Lambotte & Xavier Mariette. (2022) Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics 237, pages 108250.
Crossref
Crossref
Aneeqa Javed, Yelizaveta Medina, Amber Bux, Syeda Sahra & Geurys Rojas-Marte. (2022) Rare Case of Reversible Pulmonary Arterial Hypertension Secondary to Cyclophosphamide and Doxorubicin Chemotherapy. Cureus.
Crossref
Crossref
O. D. Ostroumova, A. I. Listratov, A. I. Kochetkov, S. A. Bliznyuk, A. G. Komarova & D. A. Sychev. (2022) Drug-induced pulmonary artery hypertension. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice:1, pages 53-63.
Crossref
Crossref
Ioannis Sagonas & Dimitrios Daoussis. (2022) Serotonin and systemic sclerosis. An emerging player in pathogenesis. Joint Bone Spine 89:3, pages 105309.
Crossref
Crossref
Zhijie Han, Xiujuan Li, Xiuli Cui, Hongjuan Yuan & Haiping Wang. (2022) The roles of immune system and autoimmunity in pulmonary arterial hypertension: A review. Pulmonary Pharmacology & Therapeutics 72, pages 102094.
Crossref
Crossref
Dongli Liu, Suyuan Qin, Danyan Su, Kai Wang, Yanyun Huang, Yuqin Huang & Yusheng Pang. (2021) Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model. ACS Omega 7:1, pages 1273-1287.
Crossref
Crossref
Lang You, Fengxia Li, Yan Sun, Liang Luo, Jian Qin, Tao Wang, Yuchen Liu, Ruogu Lai, Ruohan Li, Xiaoran Guo, Qiuyan Mai, Yihang Pan, Jianrong Xu & Ningning Li. (2021) Extract of Acalypha australis L. inhibits lipid accumulation and ameliorates HFD-induced obesity in mice through regulating adipose differentiation by decreasing PPARγ and CEBP/α expression. Food & Nutrition Research 65.
Crossref
Crossref
Rachel Blinick, Nathan Chaya, Benjamin Zalta, Linda B. Haramati & Anna Shmukler. (2021) Cracking the Opium Den. Journal of Thoracic Imaging 36:2, pages W16-W31.
Crossref
Crossref
Aleksandra Babicheva, Ayako Makino & Jason X.-J. Yuan. (2021) mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. International Journal of Molecular Sciences 22:4, pages 2144.
Crossref
Crossref
Mohammed Salahuddin, Md Dilshad Manzar, Seithikurippu R. Pandi-Perumal & Ahmed S. Bahammam. (2021) Emerging Challenges in COVID-19 With Substance Use Disorders. Addictive Disorders & Their Treatment 20:4, pages 444-453.
Crossref
Crossref
Claudia Chieffi, Cristian Camuto, Fabio De-Giorgio, Xavier de la Torre, Francesca Diamanti, Monica Mazzarino, Claudio Trapella, Matteo Marti & Francesco Botrè. (2020) Metabolic profile of the synthetic drug 4,4′-dimethylaminorex in urine by LC–MS-based techniques: selection of the most suitable markers of its intake. Forensic Toxicology 39:1, pages 89-100.
Crossref
Crossref
Md Khadem Ali, Jay C. Horvat & Edda F. Spiekerkoetter. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
407
434
.
Kalliopi Keramida, Dimitrios Farmakis, Teresa López Fernández & Patrizio Lancellotti. (2020) Focused echocardiography in cardio‐oncology. Echocardiography 37:8, pages 1149-1158.
Crossref
Crossref
Erica Simon, Rachel E. Bridwell, Tim Montrief, Alex Koyfman & Brit Long. (2020) Evaluation and management of pulmonary hypertension in the emergency department setting. The American Journal of Emergency Medicine 38:6, pages 1237-1244.
Crossref
Crossref
Liza Botros, Anton Vonk Noordegraaf & Jurjan Aman. (2020) Vanishing vessels aboding pulmonary disease: a role for VEGFR2. European Respiratory Journal 55:4, pages 2000326.
Crossref
Crossref
Johan Duflou. (2019) Psychostimulant use disorder and the heart. Addiction 115:1, pages 175-183.
Crossref
Crossref
Bashar N. Alzghoul, Amjad Abualsuod, Bilal Alqam, Ayoub Innabi, Deepak R. Palagiri, Zaid Gheith, Farah N. Amer, Nikhil K. Meena & Satish Kenchaiah. (2020) Cocaine Use and Pulmonary Hypertension. The American Journal of Cardiology 125:2, pages 282-288.
Crossref
Crossref
Joerg Herrmann. (2019) Common Vascular Toxicities of Cancer Therapies. Cardiology Clinics 37:4, pages 365-384.
Crossref
Crossref
Grazyna KwapiszewskaAnne Katrine Z. JohansenJose Gomez-ArroyoNorbert F. Voelkel. (2019) Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases. Circulation Research 125:3, pages 356-366.
Crossref
Crossref
Tieci Yi, Wei Ma, Jianxing QiuWenhui Ding. (2019) Pulmonary hypertension with massive megalosplenia. Medicine 98:12, pages e14594.
Crossref
Crossref
Jason Boswell, Holly Lowe, Katherine Adorati, Sidhartha D. Ray & Connie Rust. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
27
31
.
Deborah J. Levine, Furqan Shah & Alexander G. Duarte. (2018) PH Grand Rounds: Interferon-Associated Pulmonary Arterial Hypertension. Advances in Pulmonary Hypertension 17:3, pages 123-125.
Crossref
Crossref
Julian Maier, Felix P. Mayer, Simon D. Brandt & Harald H. Sitte. (2018) DARK Classics in Chemical Neuroscience: Aminorex Analogues. ACS Chemical Neuroscience 9:10, pages 2484-2502.
Crossref
Crossref
Taylor Buckstaff, Jenny Yang, Anna Narezkina & Timothy Fernandes. (2022) Etiology of Pulmonary Hypertension in Multiple Myeloma: A Case Series and Literature Review. SSRN Electronic Journal.
Crossref
Crossref